Syndax Pharmaceuticals Inc.

Analysts Viewpoint

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Analysts Viewpoint

Syndax Pharmaceuticals Inc’s filing revealed that its Chief Financial Officer Goldan Keith A. acquired Company’s shares for reported $25037.0 on

Insiders Updates

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

Syndax Pharmaceuticals Inc’s recently made public that its Chief Financial Officer Goldan Keith A. acquired Company’s shares for reported $25037.0

Insiders Updates

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Analysts Viewpoint

Syndax Pharmaceuticals Inc’s recently made public that its Chief Financial Officer Goldan Keith A. acquired Company’s shares for reported $25037.0

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Syndax Pharmaceuticals

Stock Earnings

In a filing, Syndax Pharmaceuticals Inc revealed its Chief Financial Officer Goldan Keith A. acquired Company’s shares for reported $25037.0

Analysts Viewpoint

Syndax Pharmaceuticals Inc’s filing revealed that its Chief Financial Officer Goldan Keith A. acquired Company’s shares for reported $25037.0 on

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Tag: Syndax Pharmaceuticals Inc.